Related Experiment Video

Updated: Jun 21, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach

James H O'Keefe1, Maia D Carter, Carl J Lavie

  • 1Mid America Heart Institute and University of Missouri-Kansas City, Missouri, USA. jhokeefe@cc-pc.com

Mayo Clinic Proceedings
|August 4, 2009
PubMed

Insights

Effective prevention of myocardial infarction and atherosclerosis complications requires lifestyle changes and aggressive multidrug therapy to manage cardiovascular risk factors. This approach reduces vascular inflammation and lowers the risk of adverse events.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Vascular Biology

Background:

  • Coronary heart disease is a leading cause of mortality despite available preventive tools.
  • Arterial inflammation and endothelial dysfunction are key in atherosclerosis pathogenesis.
  • Atherosclerosis complications significantly impact public health.

Purpose of the Study:

  • To discuss optimal therapies for primary and secondary prevention of cardiovascular events.
  • To highlight the role of managing cardiovascular risk factors.
  • To emphasize the importance of lifestyle changes and multidrug regimens.

Main Methods:

  • Review of current therapeutic strategies for cardiovascular risk factor normalization.
  • Analysis of the impact of lifestyle changes and pharmacotherapy on atherogenesis.
  • Discussion of evidence supporting aggressive management of risk factors.

Main Results:

  • Therapeutic lifestyle changes and multidrug regimens neutralize the atherogenic environment.
  • Vascular inflammation is reduced through comprehensive risk factor management.
  • Risk of adverse cardiovascular events and revascularization is significantly decreased.

Conclusions:

  • Aggressive management of cardiovascular risk factors is crucial for preventing myocardial infarction.
  • Integrated approach involving lifestyle and pharmacotherapy effectively reduces vascular inflammation.
  • Optimal therapies are essential for primary and secondary cardiovascular event prevention.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...